Trials / Unknown
UnknownNCT04904315
Subjects Through the Application of the Mindera Kit Part 2
An Exploratory, Multicenter, Observational Study to Examine RNA Biomarkers of Psoriasis Subjects Through the Application of the Mindera Kit Part 2 (STAMP-2).
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Mindera Health · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A 16 week study to examine if baseline or on-therapy transcriptomics can be used to help predict selection of medications and provide new therapeutic targets for drug development in psoriasis subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mindera Kit | The entire duration of the study, including the screening period, will be approximately 16 weeks. Mindera Kit will be applied with applicator and left on the skin for 5 minutes, and once removed, the investigational product (IP) will be placed in a buffer solution, sealed, labeled and sent to Mindera for processing. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-01-01
- Completion
- 2022-05-30
- First posted
- 2021-05-27
- Last updated
- 2021-05-27
Source: ClinicalTrials.gov record NCT04904315. Inclusion in this directory is not an endorsement.